PlainPharmaWatch

CMS Open Payments · Program Year 2024

EDW Pharma, Inc.

EDW Pharma, Inc. reported $2,611.03 across General Payments, Research, and Ownership to 23 physicians and teaching hospitals across 23 transactions.

$2.6K
All-tracks total
23
Transactions
23
Recipients
+$1.5K
General Payments vs PY2023

EDW Pharma, Inc. reported $2,611.03 across all CMS Open Payments tracks (General + Research + Ownership) to 23 physicians and teaching hospitals in Program Year 2024 - ranking #1773 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $2,611.03, averaging $113.52 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer edw-pharma-inc EDW Pharma, Inc.

$2.6K · #1773/1,925 · 0.0% industry · PY2024

  • TOT $2.6K
  • RANK #1773
  • SHARE 0.0%
  • TXN 23
  • RCP 23
  • CAT 1
  • GEN $2.6K
  • ΔGEN +$1.5K
  • TOP1 13.5%
  • PY 2024

Nearest volume peer: Maquet Critical Care AB ($2.6K)

Xiros Limited$2.6KEDW Pharma, Inc. (this)$2.6KMaquet Critical Care AB$2.6KJoline Medical Inc$2.6KMcKesson Medical-Surgical, I…$2.6K
All-tracks payment totals near EDW Pharma, Inc. (CMS Open Payments PY2024)

EDW Pharma, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

EDW Pharma, Inc.'s CMS-reported General Payments increased by $1.5K (+136.3%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: EDW PHARMA, INC.PY2023: EDW PHARMA, INC.PY2024: EDW Pharma, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$1.1KPY2024$2.6K
PY2023
$1,105.15
PY2024
$2,611.03

What the Data Shows for EDW Pharma, Inc.

In Program Year 2024, EDW Pharma, Inc. reported $2,611.03 in payments to 23 physicians and teaching hospitals across 23 individual transactions, an average of $113.52 per transaction and $113.52 per recipient. That total places EDW Pharma, Inc. at rank #1773 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Food and Beverage" leads the 1-category general-payment breakdown below at $2.6K (100.0% of General Payments, 23 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

EDW Pharma, Inc. made 1 types of general payments. "Food and Beverage" is the largest category at $2.6K, 100.0% of General Payments.

How EDW Pharma, Inc. divides its payments

Top payment categories by total reported dollar volume

1. Food and Beverage$2.6K
Payment Type Amount Transactions
Food and Beverage $2.6K 23

Recipient Concentration in General Payments

The five largest recipient relationships account for $1,586.19 (60.7%) of $2,611.03 in this company's General Payments records across 20 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for EDW Pharma, Inc.

The five named recipients with the highest reported General Payments from this company

Kevin Callerame$351.62Aimee Garza$342.72Er-Kai Gao$331.13Christopher Owen Edwards$292.24Vahid Tohidi$268.48
  1. 1

    Kevin Callerame

    $351.62 across 1 reported transactions

  2. 2

    Aimee Garza

    $342.72 across 1 reported transactions

  3. 3

    Er-Kai Gao

    $331.13 across 3 reported transactions

  4. 4

    Christopher Owen Edwards

    $292.24 across 1 reported transactions

  5. 5

    Vahid Tohidi

    $268.48 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as EDW Pharma, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about EDW Pharma, Inc..

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with EDW Pharma, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download EDW Pharma, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.